ONC-392: 27 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
27
Total FAERS Reports
1 (3.7%)
Deaths Reported
27
Hospitalizations
27
As Primary/Secondary Suspect
First Report: 20211101 · Latest Report: 20230718
What Are the Most Common ONC-392 Side Effects?
#1 Most Reported
Immune-mediated enterocolitis
8 reports (29.6%)
#2 Most Reported
Pneumonia
4 reports (14.8%)
#3 Most Reported
Colitis
4 reports (14.8%)
All ONC-392 Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Immune-mediated enterocolitis | 8 | 29.6% | 1 | 8 |
Who Reports ONC-392 Side Effects? Age & Gender Data
Gender: 42.4% female, 57.6% male. Average age: 68.1 years. Most reports from: US. View detailed demographics →
Is ONC-392 Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2021 | 1 | 0 | 1 |
| 2022 | 11 | 1 | 11 |
| 2023 | 15 | 0 | 15 |
What Is ONC-392 Used For?
| Indication | Reports |
|---|---|
| Malignant melanoma | 13 |
| Non-small cell lung cancer | 11 |
Official FDA Label for ONC-392
Official prescribing information from the FDA-approved drug label.